Burren Capital Advisors Ltd acquired a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 12,320 shares of the company's stock, valued at approximately $220,000. Grail makes up 1.1% of Burren Capital Advisors Ltd's portfolio, making the stock its 14th largest position.
Other hedge funds have also recently made changes to their positions in the company. FNY Investment Advisers LLC bought a new stake in Grail during the 4th quarter valued at approximately $26,000. Lindbrook Capital LLC purchased a new stake in Grail during the 4th quarter valued at approximately $28,000. New York State Common Retirement Fund bought a new stake in shares of Grail during the fourth quarter valued at approximately $59,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Grail in the fourth quarter worth $64,000. Finally, PNC Financial Services Group Inc. bought a new position in shares of Grail during the fourth quarter worth $86,000.
Grail Stock Up 1.0 %
Shares of GRAL traded up $0.31 during mid-day trading on Wednesday, hitting $30.85. 1,393,964 shares of the stock were exchanged, compared to its average volume of 1,224,904. Grail, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99. The firm has a 50-day moving average of $31.16 and a two-hundred day moving average of $21.08.
Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. As a group, equities analysts expect that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.
Insider Activity
In other news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the sale, the chief financial officer now owns 335,170 shares of the company's stock, valued at approximately $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the transaction, the chief executive officer now directly owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. This represents a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,550 shares of company stock worth $360,436.
Analysts Set New Price Targets
A number of analysts have issued reports on GRAL shares. Morgan Stanley began coverage on shares of Grail in a report on Wednesday, November 27th. They issued an "equal weight" rating and a $16.00 price target on the stock. Wolfe Research initiated coverage on Grail in a research report on Friday, November 15th. They set a "peer perform" rating for the company.
Read Our Latest Stock Analysis on GRAL
About Grail
(
Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Further Reading
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
